Publications en collaboration avec des chercheurs de Institut d'Investigacions Biomèdiques August Pi i Sunyer (57)

2024

  1. Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

    Biomedicine and Pharmacotherapy, Vol. 176

  2. Hallmarks of pancreatic cancer: spotlight on TAM receptors

    eBioMedicine, Vol. 107

  3. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

2023

  1. Do the negative symptoms of schizophrenia reflect reduced responsiveness to reward? Examination using a reward prediction error (RPE) task

    Psychological Medicine, Vol. 20

  2. Electrochemical immunoplatform to help managing pancreatic cancer

    Journal of Electroanalytical Chemistry, Vol. 935

  3. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    Psychiatry Research, Vol. 323

  4. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

    Cells, Vol. 12, Núm. 6

  5. Improved estimation of the risk of manic relapse by combining clinical and brain scan data

    Revista de Psiquiatria y Salud Mental

  6. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

    Nature communications, Vol. 14, Núm. 1, pp. 746

  7. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. A replication study of JTC bias, genetic liability for psychosis and delusional ideation

    Psychological Medicine, Vol. 52, Núm. 9, pp. 1777-1783

  2. Distinct roles for PARP-1 and PARP-2 in c-Myc–driven B-cell lymphoma in mice

    Blood, Vol. 139, Núm. 2, pp. 228-239

  3. Electrochemical immunosensing of Growth arrest-specific 6 in human plasma and tumor cell secretomes

    Electrochemical Science Advances, Vol. 2, Núm. 4

  4. Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway

    Psychological Medicine, Vol. 52, Núm. 10, pp. 1910-1922

  5. Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113

  6. Exploring the Role of Galectins in Cancer : In Vitro and In Vivo Approaches

    Methods in Molecular Biology (Humana Press Inc.), pp. 685-711

  7. Negative schizophrenic symptoms as prefrontal cortex dysfunction: Examination using a task measuring goal neglect

    NeuroImage: Clinical, Vol. 35

  8. Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells

    Cancers, Vol. 14, Núm. 4

  9. Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice

    Cancers, Vol. 14, Núm. 24

  10. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

    eBioMedicine, Vol. 75